Technology advancement

In Vitro Diagnostics (IVD) Market in Saudi Arabia 2021-2027

DUBLIN, August 10, 2021 /PRNewswire/ — The “Saudi Arabia In Vitro Diagnostics (IVD) Market (by Technology/Technique, Application, End-User), COVID-19 Impact, Size, Share, Key Transactions and Key Players Analysis – Forecast up to ‘in 2027’ report has been added to from ResearchAndMarkets.com offer.

The In Vitro Diagnostics (IVD) Market in Saudi Arabia is Expected to Reach US$1,242 million by 2027.

Saudi Arabia is the largest IVD market in the GCC region. As in other countries, Saudi Arabia faces challenges in the fight against infectious diseases, including HBV, tuberculosis, HCV, COVID-19 and HIV, as well as various chronic diseases and cancer. In vitro diagnostics (IVD) play an important role in the detection of infectious diseases.

In vitro diagnostics refers to the diagnosis of diseases or other conditions of the human body through the collection, preparation and testing of human samples with reagents, instruments and systems. Due to the upsurge in the geriatric population and the high burden of chronic and infectious diseases, such as diabetes, cancer, and COVID-19, the Saudi Arabia IVD market is expected to show significant growth, as these chronic disorders can be diagnosed and monitored using In Vitro Diagnostics (IVDs).

Besides, Saudi Arabia The government is taking a number of initiatives to improve the health sector in the country. The Saudi Ministry of Health foresees an expenditure of approximately SAR 23 billion on new initiatives within the healthcare industry. Saudi Arabia The government has set a target to privatize 295 hospitals by 2030, as part of the Saudi Vision 2030 plan. In addition, the government is seeking to improve the country’s healthcare sector by adopting digital information systems.

Impact of COVID-19 on the in vitro diagnostics market in Saudi Arabia

The COVID-19 outbreak has created a sense of urgency and panic among people around the world. In this scenario, in vitro diagnostics form the core of the increase in testing. Manufacturers in the in vitro diagnostics market are focused on developing new technologies for maximum testing in minimum time.

For example, in April 2021Sysmex Corporation has obtained in vitro diagnostic approval to manufacture and commercialize the DetectAmp SARS-CoV-2 RT-PCR Kit, a SARS coronavirus nucleic acid kit that detects RNA from the novel coronavirus (SARS- CoV-2).

The novel coronavirus has accelerated research and development activities in the in vitro diagnostics market. Development and production in maximum numbers is the need of the hour. Hence, rapid approvals prove to be the icing on the cake for the growth of the in vitro diagnostics market.

By Technique/Technology – Saudi Arabia In Vitro Diagnostics (IVD) Market Analysis

  • Based on technique/technology, immunoassay and clinical chemistry is the leading segment of the IVD market in Saudi Arabia.
  • Self-monitoring blood glucose (SMBG) ranks 3rd in the IVD market in Saudi Arabia in 2020.
  • Molecular Diagnostics is expected to capture a double-digit share of the IVD market in Saudi Arabia by 2027.
  • The hematology and coagulation/hemostasis segments are in tight competition to capture maximum cake market share.
  • The Point-of-Care Testing (POCT) market segment held the least share of the IVD market in Saudi Arabia.

By Application – Saudi Arabia In Vitro Diagnostics (IVD) Market Analysis

  • Based on application, infectious diseases and diabetes are major segments of the IVD market in Saudi Arabia. Together they contributed over 50% of the total IVD market in Saudi Arabia.
  • The oncology application accounted for the 3rd highest share of the IVD market in Saudi Arabia in 2020, followed by the cardiovascular disease segment.
  • Autoimmune diseases were responsible for a single-digit share of the Saudi Arabian IVD market in 2020, while the nephrology applications segment held the least share of the Saudi Arabian IVD market.

By End Users – Saudi Arabia In Vitro Diagnostics (IVD) Market Analysis

  • Government Labs & Hospitals was responsible for the lion’s share of the IVD market in Saudi Arabia in 2020.
  • In 2020, private laboratories and hospitals contributed almost a quarter of the overall IVD market in Saudi Arabia.
  • Saudi Arabia The government has set a target to privatize 295 hospitals by 2030, as part of the Saudi Vision 2030 plan.

Main topics covered:

1. Summary

2. Impact of COVID-19 on the Saudi Arabia IVD Market

3. Saudi Arabia
3.1 People
3.2 Health care expenditure per capita
3.3 Health expenditure

4. Saudi Arabia In Vitro Diagnostics (IVD) Market and Forecast (2015-2027)

5. Saudi Arabia In Vitro Diagnostics (IVD) Market Share and Forecast (2015-2027)
5.1 By Technique/Technology – Saudi Arabia In Vitro Diagnostics (IVD) Market Share and Forecast
5.2 By Application – Saudi Arabia In Vitro Diagnostics (IVD) Market Share and Forecast
5.3 By End User – Saudi Arabia In Vitro Diagnostics (IVD) Market Share and Forecast

6. By Technique/Technology – Saudi Arabia In Vitro Diagnostics (IVD) Market and Forecast (2015-2027)
6.1 Immunoassays Market and Forecast
6.2 Clinical Chemistry Market and Forecast
6.3 Hematology Market and Forecast
6.4 Coagulation/Hemostasis Market and Forecast
6.5 Microbiology Market and Forecast
6.6 Molecular Diagnostics Market and Forecast
6.7 Self-monitoring Blood Glucose (SMBG) Market and Forecast
6.8 Point-of-Care Testing (POCT) Market and Forecast

7. By Application – Saudi Arabia In Vitro Diagnostics (IVD) Market and Forecast (2015-2027)
7.1 Infectious Diseases Market and Forecast
7.2 Cardiovascular Disease Market and Forecast
7.3 Diabetes Market and Forecast
7.4 Oncology Market and Forecast
7.5 Nephrology Market and Forecast
7.6 Autoimmune Disease Market and Forecast

8. By End User – Saudi Arabia In Vitro Diagnostics (IVD) Market and Forecast (2015-2027)
8.1 In Vitro Diagnostics- Government Laboratories and Hospitals Market and Forecast
8.2 In Vitro Diagnostics – Private Laboratories and Hospitals Market and Forecast
8.3 In Vitro Diagnostics – Other Market and Forecast

9. In Vitro Diagnostics (IVD) Market – Major Offerings
9.1 2021
9.2 2020
9.3 2019
9.4 2018
9.5 2017
9.6 2016

10. Saudi Arabia IVD Market – Key Players Analysis (2013-2026)
10.1 Rock
10.1.1 Company Overview
10.1.2 Recent Initiatives/Developments
10.1.3 Sales Analysis
10.2 Abbott
10.3 Sysmex Company
10.4 Danaher Corporation
10.5 Thermo Fischer Scientific
10.6 Siemens Healthineers
10.7 Biomerieux

11. In Vitro Diagnostics (IVD) Market in Saudi Arabia – Drivers
11.1 Government Initiatives Drive In Vitro Diagnostics (IVD) Market
11.2 Growing incidence of various infectious and chronic diseases
11.3 Expand the segment of the elderly population
11.4 Advancement in Technology is Driving the IVD Market

12. Saudi Arabia In Vitro Diagnostics (IVD) Market – Challenges
12.1 Strict Regulatory Requirements and Policies
12.2 Lack of research orientation

For more information about this report visit https://www.researchandmarkets.com/r/8gxftb

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets

Related links

http://www.researchandmarkets.com